0001493152-22-035570.txt : 20221215 0001493152-22-035570.hdr.sgml : 20221215 20221215161517 ACCESSION NUMBER: 0001493152-22-035570 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221214 FILED AS OF DATE: 20221215 DATE AS OF CHANGE: 20221215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KOSKI ROBERT C CENTRAL INDEX KEY: 0001234880 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32188 FILM NUMBER: 221464978 MAIL ADDRESS: STREET 1: 1500 W UNIVERSITY PARKWAY CITY: SARASOTA STATE: FL ZIP: 34243 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ORAGENICS INC CENTRAL INDEX KEY: 0001174940 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 593410522 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4902 EISENHOWER BLVD STREET 2: SUITE 125 CITY: TAMPA STATE: FL ZIP: 33634 BUSINESS PHONE: 8132867900 MAIL ADDRESS: STREET 1: 4902 EISENHOWER BLVD STREET 2: SUITE 125 CITY: TAMPA STATE: FL ZIP: 33634 4 1 ownership.xml X0306 4 2022-12-14 0 0001174940 ORAGENICS INC OGEN 0001234880 KOSKI ROBERT C 4902 EISENHOWER BOULEVARD TAMPA FL 33634 1 0 0 0 Common Stock 2022-12-14 4 S 0 4503 0.1750 D 1310149 I See footnote Common Stock 212839 D The price reported in Column 4 was the weighted average price on the Transaction Date indicated. The shares were sold in multiple transactions ranging from $0.1700 to $0.1800 on the Transaction Date. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose. Shares owned directly by Robert C. Koski, a director of the Company. An aggregate of 53,086 shares held by individual trusts for reporting person's five children and previously reflected as part of reporting person's indirect beneficial ownership have been excluded from the reporting person's beneficial ownership as the reporting person no longer serves as trustee for the trusts. /s/ Mark A. Catchur, as Attorney-in-Fact for Robert C. Koski 2022-12-15